Lung transplant evaluation assesses patients with severe respiratory disease who may benefit from transplantation. Investigations consider lung function, other medical conditions, physical capacity and potential surgical risks. Suitability is determined through a multidisciplinary transplant assessment.
Adult lung transplantation replaces one or both diseased lungs with suitable donor organs in selected patients with advanced lung disease. The process requires extensive assessment, surgery and lifelong follow-up. Eligibility depends on the patient's diagnosis and overall health.
Paediatric lung transplant evaluation considers transplantation for selected children with advanced respiratory conditions. Assessment involves specialised teams and consideration of growth, underlying disease and long-term care. Transplantation is recommended only after detailed evaluation of possible benefits and risks.
Combined heart-lung transplantation may be considered in selected patients with severe disease affecting both organs. Evaluation includes cardiac and pulmonary investigations, assessment of associated conditions and discussion of treatment alternatives. Eligibility is determined by a multidisciplinary transplant team.
Post-transplant management includes monitoring respiratory function, evaluating infection risks, reviewing immunosuppressive medicines and assessing possible rejection. Regular specialist follow-up is essential because transplant-related complications may occur at different stages after surgery.
Lung transplant rejection occurs when the immune system reacts against the transplanted organ. Assessment may include lung function testing, imaging, bronchoscopy and tissue sampling. Treatment depends on the type and severity of rejection and requires specialist transplant management.
Chronic lung allograft dysfunction is a long-term complication that can impair breathing after lung transplantation. Monitoring focuses on lung function changes and identifying potentially reversible causes. Management requires specialist assessment and individualised treatment planning.
Pulmonary hypertension involves elevated pressure in the circulation supplying the lungs. Evaluation may include echocardiography, respiratory investigations and right heart catheterisation when indicated. Treatment depends on the specific type, cause and severity.
Interstitial lung diseases may cause progressive scarring or inflammation of lung tissue, leading to breathlessness and cough. Treatment is based on the underlying diagnosis and may include medication, pulmonary rehabilitation, oxygen support or transplant evaluation in advanced cases.
Chronic obstructive pulmonary disease causes persistent airflow limitation and breathing symptoms. Management may include inhaled medication, smoking cessation, vaccination, pulmonary rehabilitation and oxygen therapy when indicated. Long-term monitoring helps assess disease progression and complications.
Bronchoscopy uses a flexible instrument to examine the airways and obtain selected samples. It may assist in evaluating infections, abnormalities or unexplained respiratory symptoms. The procedure is performed with appropriate monitoring and patient preparation.
Endobronchial ultrasound combines bronchoscopy with ultrasound imaging to assess structures adjacent to the airways. It may guide tissue sampling from selected lymph nodes or lesions. Findings can assist in the diagnosis of inflammatory, infectious and malignant lung conditions.
Medical thoracoscopy allows direct visualisation of the pleural cavity using specialised instruments. It may be considered for unexplained pleural fluid or pleural abnormalities requiring further investigation. Tissue samples or selected treatments may be performed during the procedure.
Respiratory failure occurs when the lungs cannot maintain adequate oxygenation or carbon dioxide removal. Treatment may involve supplemental oxygen, non-invasive ventilation or invasive mechanical ventilation. Management also addresses the underlying cause of respiratory deterioration.